AWHL - Aspira Women's Health Inc.
0.3499
0.030 8.545%
Share volume: 14,014
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.32
0.03
0.09%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-19-2025 | 08-12-2025 | 11-14-2025 | |
| Total revenue | 2.279 M | 2.404 M | 2.305 M | |
| Cost of revenue | 719.000 K | 870.000 K | 922.000 K | |
| Gross profit | 1.560 M | 1.534 M | 1.383 M | |
| -1.67% | -9.84% | |||
| Operating expenses | 3.714 M | 2.665 M | 2.279 M | |
| Selling general and admin | 2.741 M | 1.961 M | 1.540 M | |
| Research and development | 973.000 K | 704.000 K | 739.000 K | |
| Total expenses | 4.800 M | 3.344 M | 2.962 M | |
| -30.33% | -11.42% | |||
| Operating income | -3.240 M | -1.810 M | -1.579 M | |
| Ebit | -1.839 M | -2.434 M | -5.888 M | |
| Pretax income | -1.853 M | -2.447 M | -5.901 M | |
| 32.06% | 141.15% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.853 M | -2.666 M | -4.892 M | |
| -43.87% | -83.50% |